Reuters - Video

エディション: US | UK | IN | CN | JP

video

Japan's Takeda takeover bid causes investor headache

2018年 4月 20日 Friday - 01:47

Takeda Pharmaceutical shares lost almost 5 percent of their value on Friday as investors fretted over the size of any deal the Japanese firm would have to make after London-listed drugmaker Shire rejected its latest $63 bln bid. As Kate King reports, Botox-maker Allergan has also pulled out of the bidding battle.

▲ ストーリーを隠す

ストーリーを表示する

Takeda Pharmaceutical shares lost almost 5 percent of their value on Friday as investors fretted over the size of any deal the Japanese firm would have to make after London-listed drugmaker Shire rejected its latest $63 bln bid. As Kate King reports, Botox-maker Allergan has also pulled out of the bidding battle.

リンクをコピーするには:URL上で右クリック後「コピー」を選択。モバイル端末では、URLを長押ししてください。

Japan's Takeda takeover bid causes investor headache

2018年 4月 20日 Friday - 01:47